{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:46:50Z","timestamp":1789469210364,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.maturitas.2026.109101","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:53:12Z","timestamp":1787669592000},"page":"109101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Incretin-based therapies in peri- and postmenopausal women with obesity: an expert position statement from the Spanish Menopause Society"],"prefix":"10.1016","volume":"213","author":[{"given":"Manuel","family":"S\u00e1nchez-Prieto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Romero-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella","family":"Lilue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Mar\u00eda","family":"Lubi\u00e1n-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia P.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An\u00edbal","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pluvio","family":"Coronado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"S\u00e1nchez-Borrego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camil","family":"Castelo-Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.maturitas.2026.109101_bb0005","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/humupd\/dmw045","article-title":"Ovarian hormones and obesity","volume":"23","author":"Leeners","year":"2017","journal-title":"Hum. Reprod. Update"},{"issue":"9","key":"10.1016\/j.maturitas.2026.109101_bb0010","doi-asserted-by":"crossref","first-page":"E1695","DOI":"10.1210\/jc.2012-1614","article-title":"Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women\u2019s Health Across the Nation","volume":"97","author":"Wildman","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.maturitas.2026.109101_bb0015","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1210\/jc.2006-1393","article-title":"Changes in body composition in women over six years at midlife: ovarian and chronological aging","volume":"92","author":"Sowers","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.maturitas.2026.109101_bb0020","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ijo.2008.25","article-title":"Increased visceral fat and decreased energy expenditure during the menopausal transition","volume":"32","author":"Lovejoy","year":"2008","journal-title":"Int. J. Obes."},{"issue":"3","key":"10.1016\/j.maturitas.2026.109101_bb0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2012-1055","article-title":"The role of estrogens in control of energy balance and glucose homeostasis","volume":"34","author":"Mauvais-Jarvis","year":"2013","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.maturitas.2026.109101_bb0030","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124865","article-title":"Changes in body composition and weight during the menopause transition","volume":"4","author":"Greendale","year":"2019","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.maturitas.2026.109101_bb0035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/13697137.2024.2374760","article-title":"Management of obesity in menopause","volume":"27","author":"Palacios","year":"2024","journal-title":"Climacteric"},{"issue":"1","key":"10.1016\/j.maturitas.2026.109101_bb0040","doi-asserted-by":"crossref","DOI":"10.1080\/09513590.2024.2312885","article-title":"Obesity and menopause","volume":"40","author":"Palacios","year":"2024","journal-title":"Gynecol. Endocrinol."},{"issue":"Suppl. 3","key":"10.1016\/j.maturitas.2026.109101_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr. Pract."},{"issue":"6","key":"10.1016\/j.maturitas.2026.109101_bb0050","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000442721","article-title":"Obesity Management Task Force of the European Association for the study of obesity. European Guidelines for Obesity Management in Adults","volume":"8","author":"Yumuk","year":"2015","journal-title":"Obes. Facts"},{"issue":"2","key":"10.1016\/j.maturitas.2026.109101_bb0055","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an endocrine society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.maturitas.2026.109101_bb0060","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.maturitas.2026.109101_bb0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.maturitas.2026.109101_bb0070","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.maturitas.2026.109101_bb0075","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.maturitas.2026.109101_bb0080","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/GME.0000000000002310","article-title":"Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use","volume":"31","author":"Hurtado","year":"2024","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.maturitas.2026.109101_bb0085","first-page":"70","article-title":"Effectiveness of low doses of semaglutide on weight loss and body composition among women in their menopause","volume":"23","author":"Nicolau","year":"2025","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"2","key":"10.1016\/j.maturitas.2026.109101_bb0090","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.ijo.0801118","article-title":"Effect of menopausal status on body composition and abdominal fat distribution","volume":"24","author":"Toth","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"4","key":"10.1016\/j.maturitas.2026.109101_bb0095","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/j.2040-4603.2018.tb00043.x","article-title":"Androgens and the regulation of adiposity and body fat distribution in humans","volume":"8","author":"Tchernof","year":"2018","journal-title":"Compr. Physiol."},{"issue":"7","key":"10.1016\/j.maturitas.2026.109101_bb0100","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamacardio.2016.2415","article-title":"Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis","volume":"1","author":"Muka","year":"2016","journal-title":"JAMA Cardiol."},{"issue":"10","key":"10.1016\/j.maturitas.2026.109101_bb0105","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/gerona\/61.10.1059","article-title":"The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study","volume":"61","author":"Goodpaster","year":"2006","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"1","key":"10.1016\/j.maturitas.2026.109101_bb0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"6","key":"10.1016\/j.maturitas.2026.109101_bb0115","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/01.AOG.0000290693.78106.9a","article-title":"Physical functioning and menopause states","volume":"110","author":"Sowers","year":"2007","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.maturitas.2026.109101_bb0120","first-page":"186","article-title":"Changes in muscle mass and strength after menopause","volume":"9","author":"Maltais","year":"2009","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"10","key":"10.1016\/j.maturitas.2026.109101_bb0125","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S2213-8587(14)70034-8","article-title":"Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases","volume":"2","author":"Kalyani","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.maturitas.2026.109101_bb0130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/dom.70141","article-title":"Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: the SEMALEAN study","volume":"28","author":"Alissou","year":"2026","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.maturitas.2026.109101_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.69","article-title":"Postmenopausal osteoporosis","volume":"2","author":"Eastell","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"5","key":"10.1016\/j.maturitas.2026.109101_bb0140","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1210\/jc.2006-0572","article-title":"Relationship of obesity with osteoporosis","volume":"92","author":"Zhao","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2026.109101_bb0145","doi-asserted-by":"crossref","DOI":"10.1007\/s11657-017-0324-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"12","author":"Compston","year":"2017","journal-title":"Arch. Osteoporos."},{"issue":"10","key":"10.1016\/j.maturitas.2026.109101_bb0150","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos. Int."},{"issue":"5","key":"10.1016\/j.maturitas.2026.109101_bb0155","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s11325-023-02793-5","article-title":"Global prevalence of sleep disorders during menopause: a meta-analysis","volume":"27","author":"Salari","year":"2023","journal-title":"Sleep Breath."},{"issue":"9","key":"10.1016\/j.maturitas.2026.109101_bb0160","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/aje\/kws342","article-title":"Increased prevalence of sleep-disordered breathing in adults","volume":"177","author":"Peppard","year":"2013","journal-title":"Am. J. Epidemiol."},{"issue":"11","key":"10.1016\/j.maturitas.2026.109101_bb0165","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S2213-8587(25)00226-8","article-title":"Once-weekly semaglutide 7\u00b72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial","volume":"13","author":"Wharton","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"14","key":"10.1016\/j.maturitas.2026.109101_bb0170","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.maturitas.2026.109101_bb0175","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"issue":"10403","key":"10.1016\/j.maturitas.2026.109101_bb0180","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(23)01185-6","article-title":"Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"402","author":"Knop","year":"2023","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.maturitas.2026.109101_bb0185","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJMoa2500969","article-title":"Oral semaglutide at a dose of 25 mg in adults with overweight or obesity","volume":"393","author":"Wharton","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.maturitas.2026.109101_bb0190","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1111\/dom.16275","article-title":"Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight","volume":"27","author":"Look","year":"2025","journal-title":"Diabetes Obes. Metab."},{"issue":"24","key":"10.1016\/j.maturitas.2026.109101_bb0195","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1056\/NEJMoa2505928","article-title":"Cardiovascular outcomes with tirzepatide versus dulaglutide in type 2 diabetes","volume":"393","author":"Nicholls","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.maturitas.2026.109101_bb0200","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.maturitas.2026.109101_bb0205","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/GME.0000000000002028","article-title":"The 2022 hormone therapy position statement of The North American Menopause Society","volume":"29","author":"\u201cThe 2022 Hormone Therapy Position Statement of The North American Menopause Society\u201d Advisory Panel","year":"2022","journal-title":"Menopause"},{"issue":"8","key":"10.1016\/j.maturitas.2026.109101_bb0210","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41574-022-00685-4","article-title":"Treating menopause - MHT and beyond","volume":"18","author":"Davis","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.maturitas.2026.109101_bb0215","series-title":"Wegovy (Semaglutide) Injection, for Subcutaneous Use: Prescribing Information","author":"Novo Nordisk","year":"2024"},{"key":"10.1016\/j.maturitas.2026.109101_bb0220","series-title":"Zepbound (Tirzepatide) Injection, for Subcutaneous Use: Prescribing Information","author":"Eli Lilly and Company","year":"2026"},{"issue":"Suppl. 4","key":"10.1016\/j.maturitas.2026.109101_bb0225","article-title":"Effect of exercise training on weight loss, body composition changes, and weight maintenance in adults with overweight or obesity: an overview of 12 systematic reviews and 149 studies","volume":"22","author":"Bellicha","year":"2021","journal-title":"Obes. Rev."},{"issue":"5","key":"10.1016\/j.maturitas.2026.109101_bb0230","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1139\/apnm-2015-0550","article-title":"Protein \u201crequirements\u201d beyond the RDA: implications for optimizing health","volume":"41","author":"Phillips","year":"2016","journal-title":"Appl. Physiol. Nutr. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2026.109101_bb0235","first-page":"86","article-title":"Dietary protein recommendations and the prevention of sarcopenia","volume":"12","author":"Paddon-Jones","year":"2009","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.maturitas.2026.109101_bb0240","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.maturitas.2020.01.005","article-title":"European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis","volume":"134","author":"Rees","year":"2020","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.maturitas.2026.109101_bb0245","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/13697137.2025.2585487","volume":"28","author":"Panay","year":"2025","journal-title":"Climacteric"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226002781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226002781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:55:31Z","timestamp":1789466131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512226002781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":49,"alternative-id":["S0378512226002781"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.109101","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incretin-based therapies in peri- and postmenopausal women with obesity: an expert position statement from the Spanish Menopause Society","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.109101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109101"}}